✦ LIBER ✦

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

✍ Scribed by Matthew T Seymour; Lindsay C Thompson; Harpreet S Wasan; Gary Middleton; Alison E Brewster; Stephen F Shepherd; M Sinead O'Mahony; Timothy S Maughan; Mahesh Parmar; Ruth E Langley

Book ID: 117308280
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 308 KB
Volume: 377
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(11)60399-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8LB Chemotherapy choices and doses in fr

8LB Chemotherapy choices and doses in frail and elderly patients with advanced colorectal cancer: an MRC randomised clinical trial (FOCUS2)

✍ M.T. Seymour; T.S. Maughan; H.S. Wasan; A.E. Brewster; S.F. Shepherd; M.S. O'Mah 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 40 KB

O.10 Chemotherapy choices and doses in f

O.10 Chemotherapy choices and doses in frail and elderly patients with advanced colorectal cancer: an MRC randomised clinical trial (FOCUS2)

✍ Seymour, M.T.; Maughan, T.S.; Wasan, H.S.; Brewster, A.E.; Shepherd, S.F.; O'Mah 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Bevacizumab plus capecitabine versus cap

Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial

✍ Cunningham, David; Lang, Istvan; Marcuello, Eugenio; Lorusso, Vito; Ocvirk, Janj 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 367 KB

Leucovorin, fluorouracil, and oxaliplati

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial

✍ Yamada, Yasuhide; Takahari, Daisuke; Matsumoto, Hiroshi; Baba, Hideo; Nakamura, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 438 KB

Interferon alfa-2a versus combination th

Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

✍ Martin E Gore; Clare L Griffin; Barry Hancock; Poulam M Patel; Lynda Pyle; Micha 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 226 KB

A Phase III Randomized, Open-Label, Cont

A Phase III Randomized, Open-Label, Controlled Trial of Chemotherapy and Bevacizumab with or Without Panitumumab in the First-Line Treatment of Patients with Metastatic Colorectal Cancer

✍ Zev Wainberg; J. Randolph Hecht 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 90 KB